Language: English
Published by Mercury Learning & Information, 2007
ISBN 10: 9814206490 ISBN 13: 9789814206495
Seller: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, United Kingdom
Condition: As New.
Language: English
Published by Focus Medica Pte Ltd, 2007
ISBN 10: 9814206490 ISBN 13: 9789814206495
Seller: Revaluation Books, Exeter, United Kingdom
CD-ROM. Condition: Brand New. cdr edition. 7.25x5.25x0.75 inches. In Stock.
Language: English
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659191035 ISBN 13: 9783659191039
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Benign Prostatic Hyperplasia : An Overview | Various treatment options for enlarged prostate | Neelima Dhingra (u. a.) | Taschenbuch | Englisch | LAP Lambert Academic Publishing | EAN 9783659191039 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659191035 ISBN 13: 9783659191039
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Dhingra NeelimaAuthor is an academician by profession with 5 yr of experience.She is specialist in synthesis and studies of medicinally important molecules.She has earned Bachelor,Masters and Ph.D in Pharmaceutical Sciences from the .
Language: English
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659191035 ISBN 13: 9783659191039
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Benign prostatic hyperplasia and its clinical manifestation as lower urinary tract symptoms is a major health concern for aging men. A better understanding of the prostate physiology, function, and pathogenesis has led to the development of number of promising agents.The specific approach used to treat BPH depends upon number of factors like age,prostrate size, weight,prostate-specific antigen level,and severity of the symptoms. 5 -reductase inhibitors decrease the production of dihydrotestosterone within the prostate,which results in decreased prostate volume, improvement of symptoms,and need for surgical intervention. 1-adrenergic receptor antagonists decrease LUTS and increase urinary flow rates in men with symptomatic BPH,but do not reduce the long-term risk of urinary retention.Clinical efficacy of either 5 -RI or 1-AR antagonist has been further improved by using combination therapy;however,long-term outcomes are still awaited. Many more potential new therapies are under development that may improve the treatment of BPH.This book gives a brief account of physiology,diagnosis, rationale and efficacy of different treatment options presently available in the management of BPH.